Period Ending | Oct 26, 2012 | Jul 27, 2012 | Apr 27, 2012 | Jan 27, 2012 |
---|
Total Revenue
|
6,209,209
|
5,498,496
|
6,104,825
|
6,731,746
| Cost of Revenue | 4,474,357 | 4,071,211 | 4,495,110 | 4,960,904 | |
Gross Profit
|
1,734,852
|
1,427,285
|
1,609,715
|
1,770,842
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 1,204,764 | 1,192,433 | 1,276,401 | 1,291,899 |
|
Non Recurring | 841,392 |
-
|
-
|
-
|
|
Others | 30,413 | 14,795 | 15,258 | 15,459 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
(341,717)
|
220,057
|
318,056
|
463,484
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (621) | 98 | 1,305 | 3,024 |
|
Earnings Before Interest And Taxes | (342,338) | 220,155 | 319,361 | 466,508 |
|
Interest Expense | 40,098 | 41,793 | 42,304 | 42,329 |
|
Income Before Tax | (382,436) | 178,362 | 277,057 | 424,179 |
|
Income Tax Expense | 175,769 | 57,967 | 90,044 | 144,153 |
|
Minority Interest | 39 | 34 | 46 | 72 |
|
|
|
Net Income From Continuing Ops | (558,166) | 120,429 | 187,059 | 280,098 | |
|
Non-recurring Events |
|
Discontinued Operations | (38,084) |
-
|
-
| 3,495 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
(596,250)
|
120,429
|
187,059
|
283,593
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
(596,250)
|
120,429
|
187,059
|
283,593
|
|